-16.5%
DRUG price history and return analytics
+52.7%
-69.2%
-96.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -9.3% | -1.1% | -8.2% | -9.4% |
| 7D | -9.3% | -2.8% | -6.5% | -9.5% |
| 30D | -60.0% | -3.9% | -56.1% | -60.2% |
| 3M | -74.2% | -6.7% | -67.5% | -74.3% |
| 6M | -73.5% | -1.3% | -72.3% | -73.5% |
| YTD | -73.7% | +7.7% | -81.4% | -73.4% |
| 1Y | -64.6% | +11.2% | -75.9% | -63.9% |
| 3Y | +1,520.1% | +63.5% | +1,456.6% | +1,290.1% |
| 5Y | -16.5% | +53.1% | -69.6% | -26.2% |
| All | -16.5% | +52.7% | -69.2% | -26.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling